Accenture Ventures takes stake in AlphaSense, sets agentic workflow partnership
The consulting firm's venture arm backs the market intelligence platform as the two move to embed AlphaSense data inside enterprise AI agents.

The consulting firm's venture arm backs the market intelligence platform as the two move to embed AlphaSense data inside enterprise AI agents.

The market intelligence platform extends its content moat and AI roadmap with fresh capital from J.P. Morgan Private Capital and Viking Global Investors.

Max Friberg's read: PE megafunds running expert calls in-house with Claude pressures the middle of the CDD stack, but the IC rubber stamp and independent perspective still anchor the engagement.

The market intelligence platform nearly doubles its valuation 18 months after a $650M Series F, and ships an autonomous research agent alongside the round.

The market-research platform's mark steps up from its $4B Series E in mid-2024 as it lines up public-market optionality.

The fundamentals-data vendor is pitching itself as the structured layer beneath ChatGPT, Claude, Perplexity, and Rogo workflows.

Guidepoint, Third Bridge, and AlphaSense have wired transcript libraries into Claude. The unit of consumption is shifting from the call to the query, and per-call ARPU has roughly 18 months to reprice.

Revenue down 6% YoY; Monocl expert-intelligence platform flagged as a bright spot on the call.

The recognition lands as flexible-talent platforms continue eating into work that once defaulted to MBB and Big Four bench teams.

An r/ATYR_Alpha post breaks down a Leerink MEDACorp expert call with two EFZO-FIT investigators ahead of readout.

The biotech adds a director who helped build one of healthcare's largest expert networks.

Leerink's expert network arm adds a pharmacoeconomics division led by Melanie Whittington, pushing further into health-economics analysis for institutional clients.

The expert network's public resource page maps the clinical questions buy-side and pharma researchers are paying to ask doctors right now.

The platform claims over 1 million verified physicians, a roster that overlaps with what hedge funds pay expert networks to access.

A directory listing surfaces the crowded field of AI-flavored financial research tools competing for analyst workflows.

London startup pitches voice-based expert onboarding as a wedge against GLG, Third Bridge, and AlphaSights.

Inex One's latest industry report puts the sector 50% above its long-cited $2B mark, with AlphaSense, Dialectica, and Capvision pulling ahead while GLG stalls.

Tokyo-listed VisasQ, which acquired Coleman Research Group in November 2021, says custom expert recruiting now averages under 24 hours.

Hourly pricing has barely moved in five years. The pressure has shifted to contract structure, transcript libraries, and multi-vendor RFPs.

Two announcements in three days position FactSet's data feed as a direct endpoint for LLM-driven research, ahead of the rest of the financial data stack.

The early-stage round backs a company building autonomous agents aimed at the work that consultants and junior analysts do today.

A 670-physician panel from the expert network points to rising LADA recognition, with CGMs and antibody panels carrying the diagnostic load.

The ingredients giant pushes deeper into high-purity stevia as reformulators chase sugar-reduction targets without the aftertaste penalty.

The market intelligence platform's recurring revenue milestone arrives alongside an editorial nod that financial-data buyers will read as competitive signal.

Inex One's 2026 client breakdown shows expert networks pushing past Wall Street, with consulting firms quietly driving nearly half the spend.

The expert network's latest primer pitches healthcare SaaS as a high-growth vertical, but the public version is thin on the numbers analysts actually need.

The expert network's recurring appearance on the FT 1000 ranking points to sustained demand for primary research, even as the category consolidates around AI-enabled platforms.

Inex One's annual market read points to a more crowded, less consolidated industry than analysts expected five years ago.

STOXX 600 constituents are tracking 3.9% earnings growth against a forecast 1.1% contraction, yet investors are punishing anything short of clean beats.

The AI-agents-for-dealmakers category keeps pulling top-tier capital, with valuations now an order of magnitude above 2024 marks.
